Women’s health biotech company Oviva Therapeutics has announced an in-licensing agreement with Massachusetts General Hospital (MGH) of a family of patents, as well as $11.5M in seed funding, to develop first-in-class therapeutics to improve healthspan, the period of life spent in good health, in women. Oviva Therapeutics addresses the vast unmet need in women’s health by expanding funding, research, and clinical development of treatments…
Maternal health startup Cayaba Care has raised $12M in Series A funding round to increase staff, launch in additional markets and further invest in technology solutions that will increase access to much-needed holistic maternity services. The round was led by Seae Ventures and Kapor Capital with participation from Wellington Partners, Citi Impact Fund, and Rhia Ventures. This round brings total funding raised to…
Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. “Black and Indigenous birthing individuals are represented in Mahmee’s population at three times the rate of the U.S. birth census and yet Mahmee’s birth outcomes are…
Mirvie‘s proprietary RNA platform combines revolutionary analysis of tens of thousands of RNA messages from the baby, the placenta and the mom, with machine learning. The platform opens a new window into pregnancy health for expecting parents to act and their doctors to intervene before unexpected complications become a crisis. It can predict preeclampsia and preterm birth months before they happen by…
A study led by researchers at Alife Health, a fertility technology company building artificial intelligence (AI) tools designed to improve in-vitro fertilization (IVF) outcomes, found that an interpretable machine learning model can help doctors optimize ovulation trigger injection timing to improve patient outcomes for a significant number of patients. When undergoing IVF, patients are prescribed fertility medications to stimulate the ovaries to…
Male fertility startup Legacy has raised $25M in funding led by Bain Capital Ventures. Other participants in the round include existing investors FirstMark Capital, Section 32 and TQ Ventures, as well as new investor Valor Equity Partners. This financing brings the company’s total funding to $45M. Legacy was founded in 2018 by Khaled Kteily with the goal to demystify male fertility by…
Menopause brand Womaness has announced a new partnership with Ulta Beauty, the largest beauty retailer in the U.S. Starting today, Womaness will be sold in select Ulta Beauty stores and online. The partnership signals an important moment in retail by providing access and visibility to items that cater specifically to the needs of the 40+ woman – an often overlooked segment. Womaness…
A couple of weeks ago Hertility took over London with its thought-provoking out-of-home campaign, but the company’s ambitions clearly aren’t limited to the UK. Today, as Hertility gears up for rapid international expansion, the company is announcing the acquisition of Netherlands-based competitor Grip. Until now, comprehensive data on women’s health hasn’t existed, but acquiring Grip will expand Hertility’s own dataset and help…
